Transparency and Cooperation

EFPIA Disclosure

Otsuka Pharmaceutical Europe Ltd (OPEL) is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). As such OPEL agrees to publically disclose certain transfers of value made directly or indirectly to healthcare professionals and healthcare organisations. This includes, but is not limited to:
  • Registration fees
  • Travel and accommodation
  • Fee for services and all consultancy
  • Any agreement related expenses or benefits (e.g. taxi, out of pocket expenses)
  • Benefits in kind
  • Contribution towards events and costs of meetings paid to healthcare organisations
  • Grants and donations
  • Research and development (in aggregate)
Where an HCP has not granted consent to disclosure on an individually named basis, these transfers of value are reported in aggregate.  For countries where Otsuka has an affiliate office, reports can be found through the tabs on the right. OPEL disclosure data for countries not covered by one of our subsidiaries can be found at the links below. Please click on the year of the data that you want to review. For further details on the methodology used to prepare the reports refer to the methodology notes for the relevant country included in the links below. Any questions relating to this information should be directed to . 2018 Data Disclosure
2017 Data Disclosure
2016 Data Disclosure
2015 Data Disclosure Otsuka Certification DISCLAIMER
  • The publication of this data is necessary in order to comply with the transparency obligations arising from the EFPIA code of practice for the Pharmaceutical Industry.
  • Access to the website of Otsuka Pharmaceutical Europe Ltd or any of its affiliate companies does not grant any right to use the disclosed data for any purpose whatsoever.
  • Otsuka Pharmaceutical Europe Ltd and its affiliates have taken reasonable steps in order to avoid indexation of the data on this website through public search engines.



Support to patient organisations and not-for-profit

Collaborations and partnerships between the pharmaceutical industry, healthcare professionals, healthcare organisations and patient organisations are subject to stringent legislation and require that all parties respect high ethical standards.  Otsuka is committed to working with Patient Organisations. These are groups that work to improve the quality of life for people with a particular disease or medical condition. Through cooperation with patient organisations, Otsuka is able to capture the “voice” of patients, their families and carers, ensuring that we understand the true aspects of living with a disease and the support that is required. 
Year External Stakeholder Group Amount Currency Description
2017 Alzheimer Europe 20,000 EUR 2017 Sponsorship and Engagement activities
EUFAMI 25,000 EUR Digital communications support
GAMIAN 12,500 EUR AGM: Digital Workshop & Patient Access
GAMIAN 12,500 EUR To support GAMIAN 2017 activities
EUFAMI 12,500 EUR EUFAMI's WSD Stigma Campaign on Quality of Life, Functioning and Early Intervention
EUFAMI 12,500 EUR Develop internal capabilities in digital communication and patient access in the context of EUFAMIs AGM
Alzheimer Europe 250 GBP Caregiver's experience Donation to Alzheimer Europe for time
Melthan Shoebox Project 250 GBP Caregiver's experience Donation to Melthan Shoebox Project for time
Promesse 4,000 EUR Donation to French Mental Health Charity following LIFE activity at ECNP
European Brain Council 10,000 EUR European Brain Council membership 2017
World Federation Mental Health 31,967.50 USD World Mental Health Day Branding Project
IEPA 36,000 EUR Digital Capabilities support to drive awareness of Early Intervention Programmes in Europe
EUFAMI 25,000 EUR Economic Burden of Caregivers Project
PKD Charity 210.00 GBP Person with Lived Experience: Expert Speaker at company event
2016 PKD Charity (UK) 12,500 GBP Grant to assist in European Fundraising Campaign
Association Polykystose France (France) 12,500 GBP Grant to assist in European Fundraising Campaign 
Swiss PKD (Switzerland) 12,500 GBP Grant to assist in European Fundraising Campaign 
PKD Familiäre Zystennieren e.V. (Germany)  12,500 GBP Grant to assist in European Fundraising Campaign 
Associatione Italiana Rene Polycystico (Italy) 12,500 GBP Grant to assist in European Fundraising Campaign 
ALCER (Spain) 12,500 GBP Grant to assist in European Fundraising Campaign 
KDIGO (Kidney Disease: Improving Global Outcomes) 50,000 EUR Donation to support 2016 Controversies Conference on Common Elements in Uncommon Kidney Diseases
PKD International 4,120  GBP Grant to assist in Press Release Development for European Fundraising Campaign
European Society for Paediatric Nephrology 15,000  EUR Grant to establish a paediatric nephrology registry
LaunchPad 90  GBP Donation to support service user led organisation
Rethink Mental Illness 800 GBP Grant to support an Advisory board for on Outcomes Based Contracting in Mental Health
ReThink Mental Illness 450 GBP Donation made on behalf of Care Giver attendance at roundtable
2015 New Horizons - Mental Health Charity 8,000 GBP Charitable donation
Friends of St Giles 500 GBP Financial support to facilitate attendance at a Behavioural Change project meeting
GAMIAN Europe 750 GBP Financial support to facilitate attendance at a Behavioural Change project meeting
EUFAMI 750 GBP Financial support to facilitate attendance at a Behavioural Change project meeting
MIND 500 GBP Financial support to facilitate attendance at a Behavioural Change project meeting
KDIGO (Kidney Disease: Improving Global Outcomes) 30,000 EUR Donation to support 2016 Controversies Conference on Common Elements in Uncommon Kidney Diseases
KDIGO (Kidney Disease: Improving Global Outcomes) 50,000 EUR Donation to support work towards improving the care and outcomes of kidney disease patients worldwide
EKPF (European Kidney Patient's Federation) 5,000 EUR Grant to assist in website upgrading and rebranding
EHKA (European Health Kidney Alliance) 5,000 EUR Sponsorship of finance the EU Kidney Forum 2015 meeting
World Federation for Mental Health 26,667 EUR Grant to help WFMH develop, build and target stakeholders within their social media platform for World Mental Health Day
IEPA Early Intervention in Mental Health 25,000 USD Support to IEPA in achieving communication of clinical and economic benefits of early intervention in mental health
Mental Health Foundation 4,000 EUR Charitable donation
Alzheimer Europe 12500 EUR Support Alzheimer Europe's work in respect to the "Guideline Watch Programme" and "Patient Advocacy Meetings"
Alzheimer's Disease International 15,000 USD Support ADI's work in respect to their annual conference and their clinical trial report
EuropaColon 500 GBP Speaker fee to EuropaColon
PKD Charity 19,130 GBP Grant to assist in the digital mapping of the PKD Charity and assessment of social media presence and influence
PKD International N/A Non-financial project management support for internal meetings
NVN (Nierpatiënten Vereniging Nederland) 5,000 EUR Unconditional Educational grant to support a range of patient orientated activities
APIR (Associacao Portuguesa de Insufientes Renais) 1,400 EUR Grant given for printing and translation of the ADPKD patient booklet.
NVN (Nierpatiënten Vereniging Nederland) 2,500 EUR Grant to support the implementation of NVN designed patient survey. The results of which will be published on the NVN website.
NierNieuws 5,000 EUR Financial support to assist with the publication of a book from the perspective of a ADPKD patient
2014   KDIGO (Kidney Disease: Improving Global Outcomes) 50,000 EUR  Donation to support publication of 2014 Controversies Conference on Autosomal Dominant Polycystic Kidney Disease (ADPKD) Report
KDIGO (Kidney Disease: Improving Global Outcomes) 200,000 EUR Donation to support 2014 Controversies Conference on Autosomal Dominant Polycystic Kidney Disease (ADPKD)
 2013  KDIGO (Kidney Disease: Improving Global Outcomes) 50,000 EUR Donation to support work towards improving the care and outcomes of kidney disease patients worldwide
SwissPKD 8,744 CHF Unrestricted grant 
PKD International 15,000 CHF Unrestricted grant
2012 KDIGO (Kidney Disease: Improving Global Outcomes) 50,000 EUR Donation to support work towards improving the care and outcomes of kidney disease patients worldwide

Support to Healthcare Organisations 

Year External Stakeholder Group Amount Currency Description
2015 DIPAK Consortium 120,000 EUR Research grant to support study maintenance in 2016
Kings College London, Institute of Psychiatry, Psychology and Neuroscience 200,000 GBP Grant to assist in the development and build of an online Carer course in collaboration with Lundbeck.
2013 Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark 110,000 EUR  Unrestricted grant
EDTA Working Group on Inherited Kidney Disorders (WGIKD) 3,000 GBP  Unrestricted grant
University of Florence, Italy 30,000 EUR  Unrestricted grant
2011 Department of Obesity and Endocrinology University Hospital Aintree, Liverpool, UK 30,000 GBP  Unrestricted grant
Neurosurgical Department Friedrich-Alexander-University, Erlangen-Nuremburg, Germany 100,000 EUR  Unrestricted grant
Nephrology University Medical Centre, Rotterdam, Netherlands 3,600 EUR  Unrestricted grant
2010 Klinik fur Pneumologie - Evangelische Lungenklinik , Berlin, Germany 60,000 EUR  Unrestricted grant

Support to patient organisations and not-for-profit - rest of Europe

Year External Stakeholder Group Amount Currency Description
2017 Nierpatiënten Vereniging Nederland (NVN) 12,000 EUR Support for ADPKD materials for patient brochure, magazine and website; patients meeting & NVN conference sponsorship
AIRG-Belgique 4,000 EUR Support for annual patient day for patients with genetic kidney disorders
Nierpatiënten Vereniging Nederland (NVN) 4,000 EUR To support delivery of digital ADPKD brochure
Nierpatiënten Vereniging Nederland (NVN) 10,000 EUR Patient Platform project to encourage self management of kidney disease and contribute to QoL
2016 Selbsthilfe Niere 5'000 EUR Unterstützung einer Veranstaltung

* The support provided by Otsuka is in no way intended as an inducement to prescribe, supply, recommend, buy or sell any products of Otsuka or any Otsuka group company, nor does Otsuka expect any favourable treatment by the institutions or any of their staff towards Otsuka personnel or representatives.

Related sections

Transparency FR Transparency UK Transparency Nordics Transparency DE Transparency CH Transparency IT Transparency ES
)